CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Kyoung Hwa Ha, Dae Jung Kim
Diabetes Metab J. 2021;45(4):505-514.   Published online October 30, 2020
DOI: https://doi.org/10.4093/dmj.2020.0057

Excel Download

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
Diabetes & Metabolism Journal. 2021;45(4):505-514   Crossref logo
Link1 Link2 Link3

Efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors as monotherapy or add‐on to metformin in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
Diabetes, Obesity and Metabolism. 2017;20(1):113-120   Crossref logo
Link1 Link2 Link3 Link4

160-LB: Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Hemodynamic and Metabolic Cardiovascular Markers in Patients with Type 2 Diabetes Mellitus
Diabetes. 2019;68(Supplement_1):   Crossref logo
Link1 Link2

The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Diabetes/Metabolism Research and Reviews. 2014;30(4):269-283   Crossref logo
Link1 Link2

An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes Mellitus
Value in Health. 2016;19(7):A665   Crossref logo
Link1 Link2

Metformin and sodium-glucose cotransporter inhibitors as therapy for type 1 diabetes mellitus: Handle with care
Revista Clínica Española (English Edition). 2020;220(1):24-26   Crossref logo
Link1 Link2

Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
The Diabetes Educator. 2015;41(1_suppl):5S-18S   Crossref logo
Link1 Link2 Link3

Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
Diabetes, Obesity and Metabolism. 2018;21(1):28-36   Crossref logo
Link1 Link2

Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis
Value in Health. 2019;22(12):1458-1469   Crossref logo
Link1 Link2

A Systematic Review and Meta-Analysis of Randomised Controlled Trials, Contrasting the Safety Profile between Sodium-Glucose Cotransporter-2 Inhibitors and Placebo in Type 1 Diabetes Mellitus Patients
International Journal of Diabetes and Metabolism. 2019;25(3-4):62-73   Crossref logo
Link1 Link2